(Q73125101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Dopamine-receptor stimulation: biobehavioral and biochemical consequences (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

A Hadj Tahar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P J Blanchet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Morissette

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Grondin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Goulet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J P Doucet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G S Robertson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Nestler

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Di Paolo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P J Bédard

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

published in

Trends in Neurosciences

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

10 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

S92-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Risk factors for levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Levodopa-induced dyskinesia: review, observations, and speculations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Is levodopa toxic to human substantia nigra?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Inhibition of levodopa effects by internal pallidal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Predictive reward signal of dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Thalamic interaction between the input and the output systems of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Inhibitory glutamatergic regulation of evoked dopamine release in striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Long-term treatment of Parkinson's disease with bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Dopamine D1 receptor desensitization profile in MPTP-lesioned primates.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

A Golgi study of the human neostriatum: neurons and afferent fibers.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Dopamine Regulation of Transcription Factor-Target Interactions in Rat Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Improvement in Tardive Dyskinesia After Muscimol Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats--an autoradiographic study using [3H]flunitrazepam

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

1 reference

7 January 2021

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1471-1931%2800%2900026-4

7 January 2021

10.1016/S1471-1931(00)00026-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11052226%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference